These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 7706271)
1. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. Schultz-Cherry S; Chen H; Mosher DF; Misenheimer TM; Krutzsch HC; Roberts DD; Murphy-Ullrich JE J Biol Chem; 1995 Mar; 270(13):7304-10. PubMed ID: 7706271 [TBL] [Abstract][Full Text] [Related]
2. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. Schultz-Cherry S; Lawler J; Murphy-Ullrich JE J Biol Chem; 1994 Oct; 269(43):26783-8. PubMed ID: 7929414 [TBL] [Abstract][Full Text] [Related]
3. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. Schultz-Cherry S; Ribeiro S; Gentry L; Murphy-Ullrich JE J Biol Chem; 1994 Oct; 269(43):26775-82. PubMed ID: 7929413 [TBL] [Abstract][Full Text] [Related]
4. The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex. Young GD; Murphy-Ullrich JE J Biol Chem; 2004 Nov; 279(46):47633-42. PubMed ID: 15342643 [TBL] [Abstract][Full Text] [Related]
5. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Guo N; Krutzsch HC; Inman JK; Roberts DD Cancer Res; 1997 May; 57(9):1735-42. PubMed ID: 9135017 [TBL] [Abstract][Full Text] [Related]
6. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. Ribeiro SM; Poczatek M; Schultz-Cherry S; Villain M; Murphy-Ullrich JE J Biol Chem; 1999 May; 274(19):13586-93. PubMed ID: 10224129 [TBL] [Abstract][Full Text] [Related]
7. Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1. Guo NH; Krutzsch HC; Inman JK; Shannon CS; Roberts DD J Pept Res; 1997 Sep; 50(3):210-21. PubMed ID: 9309585 [TBL] [Abstract][Full Text] [Related]
8. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. Tolsma SS; Volpert OV; Good DJ; Frazier WA; Polverini PJ; Bouck N J Cell Biol; 1993 Jul; 122(2):497-511. PubMed ID: 7686555 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma. Lu A; Pallero MA; Lei W; Hong H; Yang Y; Suto MJ; Murphy-Ullrich JE Am J Pathol; 2016 Mar; 186(3):678-90. PubMed ID: 26801735 [TBL] [Abstract][Full Text] [Related]
12. Thrombospondins selectively activate one of the two latent forms of transforming growth factor-beta present in adrenocortical cell-conditioned medium. Souchelnitskiy S; Chambaz EM; Feige JJ Endocrinology; 1995 Nov; 136(11):5118-26. PubMed ID: 7588249 [TBL] [Abstract][Full Text] [Related]
13. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. Schultz-Cherry S; Murphy-Ullrich JE J Cell Biol; 1993 Aug; 122(4):923-32. PubMed ID: 8349738 [TBL] [Abstract][Full Text] [Related]
14. Cooperation between thrombospondin-1 type 1 repeat peptides and alpha(v)beta(3) integrin ligands to promote melanoma cell spreading and focal adhesion kinase phosphorylation. Sipes JM; Krutzsch HC; Lawler J; Roberts DD J Biol Chem; 1999 Aug; 274(32):22755-62. PubMed ID: 10428859 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of thrombospondin 2. Binding and degradation by 3t3 cells and glycosaminoglycan-variant Chinese hamster ovary cells. Chen H; Strickland DK; Mosher DF J Biol Chem; 1996 Jul; 271(27):15993-9. PubMed ID: 8663244 [TBL] [Abstract][Full Text] [Related]
16. Molecular interactions that confer latency to transforming growth factor-beta. Young GD; Murphy-Ullrich JE J Biol Chem; 2004 Sep; 279(36):38032-9. PubMed ID: 15208302 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells. Wang S; Shiva S; Poczatek MH; Darley-Usmar V; Murphy-Ullrich JE J Biol Chem; 2002 Mar; 277(12):9880-8. PubMed ID: 11784717 [TBL] [Abstract][Full Text] [Related]
18. Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160. Olofsson A; Hellman U; Ten Dijke P; Grimsby S; Ichijo H; Morén A; Miyazono K; Heldin CH Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):427-34. PubMed ID: 9182700 [TBL] [Abstract][Full Text] [Related]
19. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo. Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272 [TBL] [Abstract][Full Text] [Related]
20. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1. Adams JC; Lawler J Mol Biol Cell; 1994 Apr; 5(4):423-37. PubMed ID: 7519904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]